Publicaciones (105) Publicaciones de Javier Cañueto Álvarez

2024

  1. Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets

    Dermatology Research and Practice, Vol. 2024

  2. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

    Journal of the European Academy of Dermatology and Venereology

  3. Immunosuppression is associated with an increased risk of distant metastases in high-risk cutaneous squamous cell carcinoma: A retrospective cohort study

    JAAD International, Vol. 15, pp. 74-77

  4. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

    Dermatology and Therapy, Vol. 14, Núm. 3, pp. 593-612

  5. Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma

    Cancers, Vol. 16, Núm. 1

  6. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245

2023

  1. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma

    Clinical and Experimental Dermatology

  2. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  3. Cutaneous metastasis of mixed neuroendocrine, sarcomatous, and squamous rectal carcinoma mimicking a Merkel cell polyomavirus-negative Merkel cell carcinoma

    Journal of Cutaneous Pathology, Vol. 50, Núm. 11, pp. 935-937

  4. Cutaneous squamous cell carcinoma: From biology to therapy

    Advances in Surgical and Medical Specialties (Taylor and Francis), pp. 393-424

  5. High-risk mucosal human papillomavirus-associated squamous cell carcinoma of the fingers presents distinctive clinicopathological characteristics and outcomes: a bicentric retrospective study

    Clinical and experimental dermatology, Vol. 48, Núm. 3, pp. 211-217

  6. Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation

    American Journal of Dermatopathology, Vol. 45, Núm. 6, pp. 378-382

  7. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

    Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127

  8. Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study

    Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693

  9. Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”

    Journal of the American Academy of Dermatology

  10. Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

    International Journal of Immunopathology and Pharmacology, Vol. 37

  11. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas

  12. Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 587-605

  13. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

  14. [Translated article] Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is It Useful?

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 3, pp. T247-T252